Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

by Begoña Campos‐Balea, Javier deCastro Carpeño, Bartomeu Massutí, David Vicente‐Baz, Diego Pérez Parente, Pedro Ruiz‐Gracia, Leonardo Crama, Manuel Cobo Dols
Published 2020-11-01

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

by Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, Jürgen R. Fischer, Oscar Juan-Vidal, David J. Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Denis Talbot, Ramaswamy Govindan, Teng Jin Ong
Published 2021-02-01